Regeneron stock sinks as fianlimab Phase 3 trial fails to meet primary endpoint. But RBC continues to see significant upside in REGN shares from here.
Pseudorabies concerns continue to weigh on lean hog prices, but bulls are hoping substitution demand at the meat counter will start to help.
Apple’s next major growth wave may come less from iPhones and more from its booming high-margin Services ecosystem, with Evercore ISI seeing a path to $13 in EPS.
Dominion Energy stock soars as NextEra announces plans of buying the power company for $67 billion. But it may not be too late to invest in D shares yet.
Markets usually have a big reaction when the Fed changes hands. Now is the time to start getting ready for Donald Trump's hawkish new chair.
SpaceX has Wall Street clearing calendars as Musk prepares a potentially record-shattering IPO debut that could steal 2026’s spotlight.
The bulls are back on more solid footing after price gains on Monday.
Berkshire Hathaway has exited its stake in Amazon while tripling its Alphabet holdings. Should you follow suit?
Core Scientific recently raised more capital while expanding its gross power capacity aggressively.
Sandisk ride in AI storage trade faces May 20 mini-tender deadline as investors stay focused on tight NAND and soaring data-center demand.
